Relmada Therapeutics (RLMD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist

2.900
+0.180+6.62%

Close Nov 27 16:00 ET

2.900
0.0000.00%

Post 17:38 ET

87.51MMarket Cap-1013P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Relmada Therapeutics to Present at Jefferies London Healthcare Conference
GlobeNewswireNov 19 09:00 ET
Express News | Relmada Therapeutics Inc - Phase 2a Proof-of-Concept Study Expected to Begin in H1 2025
ReutersNov 14 07:31 ET
Express News | Relmada Therapeutics Initiates Phase 1 Dosing With Rel-P11 for Metabolic Disease
ReutersNov 14 07:30 ET
Relmada Therapeutics Initiates Phase 1 Dosing With REL-P11 for Metabolic Disease
GlobeNewswireNov 14 07:30 ET
Relmada Therapeutics: Strong Buy on Promising Pipeline and Financial Stability
TipRanksNov 11 01:27 ET
Relmada Therapeutics, Inc. (RLMD) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 10 09:59 ET · Conference Call

Comments

农村巴菲特

Nov 20 14:34

$Relmada Therapeutics (RLMD.US)$ this is not good

72824481

Oct 28 06:14

$Relmada Therapeutics (RLMD.US)$ just waiting for a ANY reason to run now

72824481

Oct 25 13:45

$Relmada Therapeutics (RLMD.US)$ this one i think it will run in 2 weeks hope so

农村巴菲特

Oct 25 09:15

$Relmada Therapeutics (RLMD.US)$ go go

Daight

Sep 19 17:29

Some stocks you can sorta bag hold for awhile. Not financial advice, just me thinking out loud.
$Banzai International (BNZI.US)$
super low float, just after r/s, might fly.
watch before you buy, find the range you think is lowest, then start in small position and scale from there. set stop loss in comfortable range.
insider buy and stable(for now)
$Forza X1 (FRZA.US)$ < below 0.3 would be ideal
$Relmada Therapeutics (RLMD.US)$ < below 3 would be ideal
$Phoenix Motor (PEV.US)$ < below 0.4 wou...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

RLMD Relmada Therapeutics

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target